Talimogene laherparepvec [electronic resource] : first-in-class oncolytic immunotherapy / Kevin Harrington.
Material type:
FilmSeries: Henry Stewart talksBiomedical & life sciences collection. Immunotherapy of cancer: Publisher: London : Henry Stewart Talks, 2016Description: 1 online resource (1 streaming video file (44 min.) : color, sound)Subject(s): Cancer -- Immunotherapy | Drug targeting | Melanoma -- Immunotherapy | Viruses -- Therapeutic use | Adjuvants, Immunologic -- therapeutic use | Antineoplastic Agents -- therapeutic use | CD8-Positive T-Lymphocytes -- immunology | Granulocyte-Macrophage Colony-Stimulating Factor -- immunology | Herpesvirus 1, Human | Immunotherapy -- methods | Melanoma -- immunology | Melanoma -- therapy | Neoplasms -- immunology | Neoplasms -- therapy | Oncolytic Virotherapy | Simplexvirus -- geneticsOnline resources: Click here to access online | Series Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: Causing tumour cell lysis -- Initiating a specific systemic immune response -- T-VEC as an oncolytic HSV-1 strain -- Assessing cancer immunotherapy through melanoma -- Applicability of oncolytic viral therapy to various cancers.
Access restricted to subscribers.
Mode of access: World Wide Web.